Long-term effectiveness of a new Ξ±-gluco
β
Mitrakou, A.; Tountas, N.; Raptis, A.E.; Bauer, R.J.; Schulz, H.; Raptis, S.A.
π
Article
π
1998
π
John Wiley and Sons
π
English
β 83 KB
π 1 views
In a double-blind, randomized study, miglitol (BAY m 1099), an β£-glucosidase inhibitor, 100 mg tds or placebo was given orally with meals for a period of 24 weeks in 117 patients with Type 2 (non-insulin-dependent) diabetes mellitus (DM) treated with insulin. Fasting and 1 h postprandial plasma gluc